Please use this identifier to cite or link to this item: 10.1161/CIRCULATIONAHA.116.025427
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAPEX Investigators-
dc.contributor.authorStukena, I.-
dc.date.accessioned2021-05-18T08:55:01Z-
dc.date.available2021-05-18T08:55:01Z-
dc.date.issued2017-02-14-
dc.identifier.citationAPEX Investigators & Stukena , I 2017 , ' Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients : An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) ' , Circulation , vol. 135 , no. 7 , pp. 648-655 . https://doi.org/10.1161/CIRCULATIONAHA.116.025427-
dc.identifier.issn0009-7322-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/4351-
dc.descriptionMembers of the APEX Investigators working group are listed in Web of Science database publication.-
dc.format.extent181430-
dc.language.isoeng-
dc.relation.ispartofCirculation-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectanticoagulants-
dc.subjectcardiology-
dc.subjectcardiovascular diseases-
dc.subjectintracranial hemorrhages-
dc.subjectstroke-
dc.subjectthrombosis-
dc.subject3.2 Clinical medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.subjectSDG 3 - Good Health and Well-being-
dc.titleExtended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients : An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.1161/CIRCULATIONAHA.116.025427-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Extended_Duration_Betrixaban.pdf177.18 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.